Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/CHMP-Issues-Positive-Opinion-for-Biogen-s-SKYCLARYS-omaveloxolone-the-First-Therapy-to-Treat-45579887/?utm_source=whatsapp&utm_medium=social&utm_campaign=share